IA Day Take 2: Seeking to Re-establish Consistent Compounder, Proof Required

Research evidence excerpt

IA Day Take 2: Seeking to Re-establish Consistent Compounder, Proof Required

TD Cowen Fiserv

Global Research May 15, 2026

Key Highlights from Investor Day 2026

■Strategic Reset: "One Fiserv" + Return to Constant Compounder: FISV used the Investor Day

to re-frame the story around execution and consistency, seeking to reestablish the business

as a "constant compounder" driven by its One Fiserv plan. Management acknowledged prior

execution issues across service, product delivery, and core attrition, but emphasized the

strength of the franchise, with the strategy centered on five pillars: client-first execution,

scaling Clover, accelerating product delivery, AI-led productivity, and disciplined capital

allocation. The goal is to restore durable mid-single-digit growth, sustained margin

expansion, and strong FCF. In our view, the key shift is less about strategy change and more

about execution accountability, which should improve credibility if the 2H ramp materializes

as expected.

■Margin expansion underwritten by structural levers & growth recovery. Management

outlined a multi-year margin framework anchored by ~50bps of annual underlying

operating leverage, driven by scale, mix shift to higher-value products (Clover & VAS), and

a largely fixed cost base. On top of this, Project Elevate is expected to deliver >200bps

of incremental margin expansion by 2029 ($500M+ of run-rate cost savings), tied to

technology modernization, process simplification, vendor optimization, and broader

organizational efficiency initiatives. Importantly, 2026 represents an investment year ($1B+

of incremental spend across people and technology), positioning ~34% adjusted operating

margin as the starting point, with expansion back-end weighted as cost actions ramp. Taken